Seagen
SGEN
#541
Rank
A$64.91 B
Marketcap
A$344.09
Share price
-0.07%
Change (1 day)
63.60%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -A$1.2 Billion

According to Seagen 's latest financial reports the company's current earnings are A$2.30 Billion. In 2022 the company made an earning of -A$0.93 Billion, an increase over its 2021 earnings that were of -A$1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$1.2 Billion29.37%
2022 -A$0.93 Billion-10.13%
2021 -A$1.03 Billion-214.28%
2020 A$0.89 B-370.63%
2019 -A$0.34 Billion-15.17%
2018 -A$0.4 Billion32.79%
2017 -A$0.3 Billion37.19%
2016 -A$0.22 Billion18%
2015 -A$0.19 Billion56.34%
2014 -A$0.12 Billion23.07%
2013 -A$94.57 Million
2011 -A$0.22 Billion111.72%
2010 -A$0.11 Billion-19.63%
2009 -A$0.13 Billion-7.55%
2008 -A$0.14 Billion64.95%
2007 -A$83.71 Million38.4%
2006 -A$60.49 Million25.36%
2005 -A$48.25 Million-14.86%
2004 -A$56.67 Million61.92%
2003 -A$35 Million-7.67%
2002 -A$37.91 Million6.76%
2001 -A$35.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-A$94.44 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.86 B-340.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.39 Billion-67.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$93.09 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.82 B-1,599.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.02 B-1,279.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
A$2.49 B-309.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.08 B-1,116.09%๐Ÿ‡บ๐Ÿ‡ธ USA